Skip to main content

Botanix Pharmaceuticals Health Care

$0.130 0.025 (23.81%)

High

$0.13

Low

$0.11

Trades

273

Turnover

$1,647,025

Volume

13,196,801
30 June 2023 at 4:45pm
Register to track BOT and receive email alerts.
BOT Announcements on Price Chart

Latest Announcements

Headline Date
Section 708A(5)(e) Notice 27 June 2023 at 7:35pm
Application for quotation of securities - BOT 27 June 2023 at 7:35pm
Section 708A(5)(e) Notice 15 June 2023 at 2:35pm
Application for quotation of securities - BOT 15 June 2023 at 2:35pm
Investor Webinar Presentation 7 June 2023 at 11:20am
New Territory Licensed for Sofpironium Bromide with Kaken 5 June 2023 at 12:10pm
Pause in trading 5 June 2023 at 10:20am
Botanix Investor Webinar 2 June 2023 at 10:59am
Change of Director's Interest Notice x 3 22 May 2023 at 7:40pm
Notification of cessation of securities - BOT 22 May 2023 at 7:35pm
Appendix 2A and Section 708A(5)(e) Notice - amended 22 May 2023 at 7:35pm
Notice Under Section 708A(5)(e) of the Corporations Act 18 May 2023 at 7:45pm
Application for quotation of securities - BOT 18 May 2023 at 7:40pm
March 2023 Quarterly Activities Report and Appendix 4C 28 April 2023 at 2:20pm
Change in substantial holding from IFL 18 April 2023 at 5:05pm
Company Secretary Change 17 April 2023 at 8:50am
Botanix successfully completes A$10m Placement Revised 13 April 2023 at 12:45pm
Botanix successfully completes A$10m Placement 13 April 2023 at 9:55am
Notice under Section 708A(5)(e) of the Corporations Act 13 April 2023 at 9:55am
Application for quotation of securities - BOT 13 April 2023 at 9:50am
Application for quotation of securities - BOT 13 April 2023 at 9:50am
Investor Update 5 April 2023 at 10:15am
Proposed issue of securities - BOT 5 April 2023 at 10:15am
Botanix Raises A$10 million via Institutional Placement 5 April 2023 at 10:15am
Trading Halt 3 April 2023 at 9:55am
FDA Mid-Cycle Review Meeting Successfully Completed 3 April 2023 at 9:10am
Change of Director's Interest Notice * 5 20 March 2023 at 6:30pm
Notice under Section 708A(5)(e) of the Corporations Act 20 March 2023 at 6:30pm
Application for quotation of securities - BOT 20 March 2023 at 6:20pm
Application for quotation of securities - BOT 20 March 2023 at 5:55pm
Notification regarding unquoted securities - BOT 14 March 2023 at 7:50pm
Response to ASX Price and Volume Query 10 March 2023 at 7:15pm
Webinar Updated Commercial Research for Sofpironium Bromide 9 March 2023 at 10:30am
Botanix To Host Investor Webinar 8 March 2023 at 3:25pm
Half Yearly Report and Accounts 28 February 2023 at 5:05pm
Press Article Correction 15 February 2023 at 10:05am
Trading Halt 14 February 2023 at 11:50am
Pause in Trading 14 February 2023 at 10:20am
Investor Presentation and Video 31 January 2023 at 10:05am
Appendix 4C - Quarterly 31 January 2023 at 9:45am
Botanix attends JP Morgan Healthcare Conference 9 January 2023 at 9:55am
Change of Director's Interest Notice * 5 4 January 2023 at 10:30am
Notification regarding unquoted securities - BOT 4 January 2023 at 10:20am
Change of Director's Interest Notice *5 14 December 2022 at 7:10pm
Notice under Section 708A(5)(e) of the Corporations Act 12 December 2022 at 3:20pm
Application for quotation of securities - BOT 12 December 2022 at 3:10pm
Notification regarding unquoted securities - BOT 12 December 2022 at 3:00pm
Confirmation Sofpironium Bromide NDA Formally Under Review 8 December 2022 at 10:05am
Application for quotation of securities - BOT 30 November 2022 at 12:20pm
Notice Under Section 708A(5)(e) of the Corporations Act 2001 29 November 2022 at 9:45am
Register to track BOT and receive email alerts.